Vlad Coric

Companies

• Veradermics, IncBoard member Feb 3, 2026 to now¹
• Royalty Pharma plcBoard member Apr 21, 2025 to now²
• Biohaven PharmaceuticalsBoard member Sep 28, 2022 to now³
• Biohaven PharmaceuticalsChief executive officer Sep 28, 2022 to now³
• Revance Therapeutics, Inc.Board member Mar 3, 2023 to Feb 6, 2025⁴
• Biohaven Pharmaceutical Holding Co Ltd.Board member May 3, 2017 to Oct 3, 2022⁵
• Biohaven Pharmaceutical Holding Co Ltd.Chief executive officer May 3, 2017 to Oct 3, 2022⁵
• Akili, Inc.Board member Jun 29, 2021 to Jun 29, 2021⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• VVeradermics, Inc MANE449,337 shares⁷$51.7M at $115.07Feb 5, 2026
• Biohaven Pharmaceuticals BHVN1,913,533 shares⁸$20.6M at $10.78Jan 7, 2026
• RPRoyalty Pharma plc RPRX15,343 shares⁹$917.7K at $59.81Jun 5, 2026
• RTRevance Therapeutics, Inc.0 shares¹⁰Feb 6, 2025
• BPBiohaven Pharmaceutical Holding Co Ltd.830,891 shares¹¹Oct 3, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 5, 2026Granted 4,545 shares of Royalty Pharma plc⁹
• Feb 5, 2026Bought 58,823 shares at $17.00 of Veradermics, Inc⁷
• Feb 5, 2026Bought 58,823 shares at $17.00 of Veradermics, Inc⁷
• Feb 5, 2026Converted 117,112 shares of Veradermics, Inc⁷
• Feb 5, 2026Converted 78,075 shares of Veradermics, Inc⁷
• Feb 5, 2026Converted 78,075 shares of Veradermics, Inc⁷
• Feb 5, 2026Converted 148,794 shares of Veradermics, Inc⁷
• Feb 5, 2026Converted 148,794 shares of Veradermics, Inc⁷
• Feb 5, 2026Converted 33,706 shares of Veradermics, Inc⁷
• Feb 5, 2026Converted 33,706 shares of Veradermics, Inc⁷
• Jan 5, 2026Shares withheld for tax 7,430 shares at $9.93 of Biohaven Pharmaceuticals⁸
• Jan 5, 2026Exercised options 14,250 shares of Biohaven Pharmaceuticals⁸
• Nov 13, 2025Bought 333,333 shares at $7.50 of Biohaven Pharmaceuticals¹²
• Nov 13, 2025Bought 333,333 shares at $7.50 of Biohaven Pharmaceuticals¹²
• May 13, 2025Granted 7,614 shares of Royalty Pharma plc¹³
• Apr 21, 2025Granted 3,184 shares of Royalty Pharma plc¹⁴
• Feb 6, 2025Returned to company 15,000 shares of Revance Therapeutics, Inc.¹⁰
• Feb 4, 2025U 5,784 shares at $3.65 of Revance Therapeutics, Inc.¹⁰
• Jan 5, 2025Shares withheld for tax 6,805 shares at $38.64 of Biohaven Pharmaceuticals¹⁵
• Jan 5, 2025Exercised options 14,250 shares of Biohaven Pharmaceuticals¹⁵
• Oct 2, 2024Bought 21,052 shares at $47.50 of Biohaven Pharmaceuticals¹⁶
• May 1, 2024Granted 15,000 shares of Revance Therapeutics, Inc.¹⁷
• Apr 22, 2024Bought 121,951 shares at $41.00 of Biohaven Pharmaceuticals¹⁸
• Apr 5, 2024Granted 231 shares of Biohaven Pharmaceuticals¹⁹
• Apr 5, 2024Granted 231 shares of Biohaven Pharmaceuticals¹⁹